264.35
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché THC Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$265.05
Aprire:
$261.07
Volume 24 ore:
99,245
Relative Volume:
0.09
Capitalizzazione di mercato:
$21.28B
Reddito:
$21.46B
Utile/perdita netta:
$2.65B
Rapporto P/E:
13.75
EPS:
19.2312
Flusso di cassa netto:
$3.35B
1 W Prestazione:
-0.52%
1M Prestazione:
+0.89%
6M Prestazione:
+11.61%
1 anno Prestazione:
+37.41%
Tenet Healthcare Corp Stock (THC) Company Profile
Nome
Tenet Healthcare Corp
Settore
Industria
Telefono
469-893-2200
Indirizzo
14201 DALLAS PARKWAY, DALLAS, TX
Compare THC vs HCA, FMS, EHC, DVA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
THC
Tenet Healthcare Corp
|
264.27 | 21.34B | 21.46B | 2.65B | 3.35B | 19.23 |
|
HCA
Hca Healthcare Inc
|
405.95 | 87.68B | 76.39B | 7.81B | 7.93B | 29.08 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.56 | 12.06B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
121.60 | 12.01B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
DVA
Davita Inc
|
181.89 | 11.74B | 13.84B | 1.10B | 1.49B | 10.42 |
Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-14 | Ripresa | Goldman | Buy |
| 2025-07-28 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-05-29 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Iniziato | Morgan Stanley | Overweight |
| 2025-02-26 | Iniziato | TD Cowen | Buy |
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-12-16 | Downgrade | Goldman | Buy → Neutral |
| 2024-11-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-27 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Iniziato | JP Morgan | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-03-29 | Iniziato | Wells Fargo | Overweight |
| 2022-02-10 | Aggiornamento | UBS | Neutral → Buy |
| 2022-02-09 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-02-09 | Aggiornamento | Truist | Hold → Buy |
| 2022-01-20 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2022-01-10 | Ripresa | Citigroup | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-09-24 | Iniziato | UBS | Neutral |
| 2021-08-12 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-07-23 | Ripresa | Citigroup | Buy |
| 2021-07-09 | Iniziato | Seaport Global Securities | Buy |
| 2021-05-03 | Ripresa | Goldman | Buy |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-01-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-15 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-03-11 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-26 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2019-12-09 | Aggiornamento | UBS | Neutral → Buy |
| 2019-11-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-08-14 | Ripresa | Goldman | Neutral |
| 2019-02-26 | Reiterato | BofA/Merrill | Neutral |
| 2019-01-14 | Iniziato | Stephens | Equal-Weight |
| 2019-01-03 | Iniziato | Deutsche Bank | Hold |
| 2018-12-17 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-11-16 | Iniziato | UBS | Neutral |
| 2018-06-29 | Downgrade | Jefferies | Buy → Hold |
| 2018-03-23 | Ripresa | Mizuho | Buy |
| 2018-01-30 | Ripresa | Wells Fargo | Market Perform |
| 2018-01-03 | Iniziato | Goldman | Neutral |
| 2017-12-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-19 | Reiterato | Mizuho | Neutral |
| 2017-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Tenet Healthcare Corp Borsa (THC) Ultime notizie
THC Looks 42.8% Overvalued on GF Value™ - GuruFocus
Tenet Healthcare offers $1.5B notes to refinance 2027 debt - Investing.com
Tenet could refinance $1.5B due in 2027 with notes due in 2034. - Stock Titan
ETFs Investing in Tenet Healthcare Corporation Stocks - TradingView
HCA Healthcare Inc. stock underperforms Friday when compared to competitors - MarketWatch
BlackRock controls millions of Tenet Healthcare (NYSE: THC) shares, but how much voting power is solely its own? - Stock Titan
Tenet Healthcare (NYSE:THC) Looks Like a Decent Value Stock With Strong Profitability - ChartMill
Tenet Healthcare director Nadja West sells $298,137 in stock By Investing.com - Investing.com South Africa
Tenet Healthcare director Nadja West sells $298,137 in stock - Investing.com
Tenet Healthcare (NYSE: THC) director sells about $298K in shares - Stock Titan
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
Director at Tenet Healthcare (NYSE: THC) plans 1,152-share Rule 144 stock sale in September 2026 - Stock Titan
Lisa Y Foo Takes Money Off The Table, Sells $6.39M In Tenet Healthcare Stock - Benzinga
Tenet Healthcare and Archrock have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Tenet to Participate in the Wells Fargo Healthcare Conference - Barchart.com
Tenet Healthcare COO Lisa Foo sells $6.39m in shares By Investing.com - Investing.com Australia
Tenet Healthcare COO Lisa Foo sells $6.39m in shares - Investing.com
Tenet Healthcare Corporation (THC) Peer Comparison – Compare with Others - Value Research
Charitable stock gift trims Tenet (THC) insider’s direct stake to 12,403 shares - Stock Titan
Tenet (THC) officer discloses new stock sale after July trade - Stock Titan
Tenet Healthcare Corporation (THC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
CEO At Tenet Healthcare Sells $27.64M Of Stock - Benzinga
Tenet healthcare CEO Saumya Sutaria sells $27.6m in shares By Investing.com - Investing.com Nigeria
Tenet healthcare director Cecil Haney sells $361,438 in stock By Investing.com - Investing.com Canada
Tenet Healthcare (NYSE: THC) holder plans new sale after $13.9M trade - Stock Titan
Tenet Healthcare (NYSE: THC) director lines up $361K share sale - Stock Titan
Tenet Healthcare (THC): Sutaria files 50,000-share resale notice - Stock Titan
Tenet Healthcare Corp (THC) Stock Up 3.0% but GF Value Says Over - GuruFocus
Tenet Healthcare Corp (MIL:1THC) Stock Price, Trades & News - GuruFocus
Tenet (THC) Is Considered a Good Investment by Brokers: Is That True? - Yahoo Finance
Zacks Industry Outlook Highlights Tenet Healthcare, Universal Health Services, Acadia Healthcare and Community Health Systems - Eastern Progress
HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
Tenet Healthcare stock hits all-time high at 270.79 USD - Investing.com
Zacks.com featured highlights include Centene, Tenet Healthcare, Fortinet, Unity Software and Goldman Sachs - Zacks Investment Research
Can Tenet Healthcare's Hospital Growth Keep Earnings Momentum Going? - Yahoo Finance
Tenet Healthcare director Roy Blunt sells $157,608 in company stock By Investing.com - Investing.com South Africa
Tenet Healthcare Corp (THC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tenet Healthcare director Roy Blunt sells $157,608 in company stock - Investing.com
Tenet Healthcare (NYSE:THC) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat
Tenet Healthcare Faces 30%-35% Downside After Its 26-Fold Surge - Investing.com
T. Rowe Price stakes 9.2% in Tenet Healthcare (THC) with 7.96M shares - Stock Titan
Are Investors Undervaluing Tenet Healthcare (THC) Right Now? - Yahoo Finance
Tenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Zacks Research Brokers Boost Earnings Estimates for THC - MarketBeat
Is Tenet Healthcare (THC) Overvalued Following Higher 2026 Adjusted EPS Guidance? - simplywall.st
Tenet Healthcare (THC) Could Be 7% Above Fair Value As Golden Cross Draws Focus - Yahoo Finance
Tenet Healthcare (NYSE:THC) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Is Tenet’s Golden Cross, Higher EPS Guidance and Ambulatory Push Altering The Investment Case For Tenet Healthcare (THC)? - Yahoo Finance
Tenet Healthcare (NYSE:THC) Sets New 1-Year HighStill a Buy? - MarketBeat
Here's How Much You'd Have If You Invested $1000 in Tenet Healthcare a Decade Ago - Yahoo Finance
Wedge Capital Management L L P NC Grows Holdings in Tenet Healthcare Corporation $THC - MarketBeat
Tenet Healthcare Corp Azioni (THC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):